X
Breakthrough designation for Roche/Novartis’ Xolair in food allergies
https://pharmaphorum.com/news/breakthrough-designation-for-roche-novartis-xolair-in-food-allergies/
Genentech
Genentech’s Rituxan approved for rare skin disease
The FDA has approved Genentech’s Rituxan (rituximab) for use in adults with moderate-to-severe pemphigus vulgaris (PV), making it the first treatment for the condition in more than 60 years.
Calling all Microbiologists – 5 great reasons to be in San Diego
Pharmaceutical Microbiology West Coast Conference 2018
Roche and AC Immune’s Alzheimer’s drug on right track
Data suggest high dose used in phase 3 trial is most effective
Three’s a crowd as Tecentriq approved in lung cancer
Cancer immunotherapy approved in second line.
Genentech’s Xolair gets US paediatric use
Drug approved for asthma in children.
A history of Roche
A delve into the history of Roche
